Technical Slide Library
Subject
- Fibrin sealants & components
- Components of fibrin sealants
- Thrombin
- Aprotinin
- Mechanism of action
- Clinical safety of Beriplast® P Combi-Set
- Beriplast® P Combi-Set: integrated safety system
- Beriplast® P Combi-Set ISS: controls
- Beriplast® P Combi-Set: NAT/PCR used to test plasma donations
- Beriplast® P Combi-Set ISS: virus inactivation and elimination
- Validation of virus Inactivation/elimination
- Viral reduction in Beriplast® P Combi-Set production
- Beriplast® P Combi-Set log10 viral reduction factors: human fibrinogen
- Aprotinin and transmissible spongiform encephalopathy (TSE) risk
- Beriplast® P Combi-Set: adverse reactions
- Estimated risks of adverse events in clinical practice
- Beriplast® P Combi-Set: conclusions
- Experimental models
- Fibrin sealants increase the tensile strength of ruptured membranes in vitro
- Fibrin sealants strengthen colonic anastomoses
- Fibrin sealants strengthen vascular anastomoses
- Fibrin sealant reduces suture hole bleeding in a pig vascular graft model
- Effective haemostasis with fibrin sealant in experimental liver injury
- Comparison of two commercially available fibrin sealants
- Less force needed to deliver low viscosity fibrin sealants through delivery devices
- Strength of adhesion is inversely related to treatment viscosity
- Delivery devices
- Pantajet® dual syringe in open surgery
- Application of fibrin sealant in minimal invasive surgery
- Application of fibrin sealant through double-lumen probe in endoscopy
- Double-lumen probe (no needle) for use in endoscopy
- Flexible catheter for spray delivery
- Fibrin sealants
- Fibrinogen
- Factor XIII
- Calcium chloride
- Beriplast® P Combi-Set safety & tolerability
- Safety of Beriplast® P Combi-Set
- Beriplast® P Combi-Set ISS: safety at the source
- Beriplast® P Combi-Set: window period reduction by PCR
- Beriplast® P Combi-Set: virus elimination and inactivation steps
- Beriplast® P Combi-Set: viruses used in validation studies
- Beriplast® P Combi-Set log10 viral reduction factors: human thrombin
- Beriplast® P Combi-Set log10 viral reduction factors: human factor XIII
- Beriplast® P Combi-Set ISS: final product testing
- Beriplast® P Combi-Set: drug surveillance
- Safety of Beriplast® P Combi-Set
- Preclinical uses of fibrin sealant
- Fibrin sealants enhance tensile strength of intraocular wounds
- Human plasma derived fibrin sealants produce strong wound closure
- Fibrin sealants strengthen watertight sutures
- Effect of fibrin sealant in a femoral artery injury model
- Effective haemostasis in experimental atrial rupture
- Viscosity and delivery of fibrin sealants
- Viscosity of fibrin sealants
- Fibrin sealant reduces rate of adhesion formation in a rat model
- Fibrin sealant inhibits pericardial adhesions after cardiac surgery in dogs
- Fibrin sealants
- Application of fibrin sealant through spray tip in open surgery
- Application of fibrin sealant in minimal invasive surgery
- Application of fibrin sealant through double-lumen probe in endoscopy
- Application of fibrin sealant with double-lumen cannulae in microsurgery
- Flexible catheter
